Insider Transactions in Q3 2022 at Alphatec Holdings, Inc. (ATEC)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 29
2022
|
David H Mowry |
SELL
Open market or private sale
|
Direct |
4,370
-4.54%
|
$30,590
$7.85 P/Share
|
|
Aug 17
2022
|
Elizabeth Ann Altman |
SELL
Open market or private sale
|
Direct |
8,009
-16.53%
|
$72,081
$9.06 P/Share
|
|
Aug 17
2022
|
Craig E Hunsaker EVP, PEOPLE & CULTURE |
SELL
Open market or private sale
|
Direct |
9,895
-0.78%
|
$89,055
$9.07 P/Share
|
|
Aug 16
2022
|
Craig E Hunsaker EVP, PEOPLE & CULTURE |
SELL
Open market or private sale
|
Direct |
900
-0.07%
|
$8,100
$9.5 P/Share
|
|
Aug 15
2022
|
Craig E Hunsaker EVP, PEOPLE & CULTURE |
SELL
Open market or private sale
|
Direct |
30,000
-2.32%
|
$270,000
$9.7 P/Share
|
|
Aug 11
2022
|
David Sponsel EVP, SALES |
SELL
Payment of exercise price or tax liability
|
Direct |
620
-0.11%
|
$4,960
$8.91 P/Share
|
|
Aug 10
2022
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,000
+25.0%
|
$16,000
$8.04 P/Share
|
|
Aug 10
2022
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
2,000
+3.83%
|
$16,000
$8.1 P/Share
|
|
Aug 09
2022
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,100
+21.15%
|
$14,700
$7.85 P/Share
|
|
Aug 09
2022
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
2,000
+3.98%
|
$14,000
$7.97 P/Share
|
|
Aug 05
2022
|
Patrick Miles CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
57,443
-1.07%
|
$459,544
$8.03 P/Share
|
|
Aug 05
2022
|
Craig E Hunsaker EVP, PEOPLE & CULTURE |
SELL
Payment of exercise price or tax liability
|
Direct |
9,760
-0.75%
|
$78,080
$8.03 P/Share
|
|
Aug 05
2022
|
Brian Snider EVP, MARKETING |
SELL
Payment of exercise price or tax liability
|
Direct |
6,805
-1.03%
|
$54,440
$8.03 P/Share
|
|
Aug 05
2022
|
Kelli Mari Howell EVP, CLINICAL STRATEGIES |
SELL
Payment of exercise price or tax liability
|
Direct |
6,050
-1.11%
|
$48,400
$8.03 P/Share
|